BioSilta Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:BioSilta Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013143
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioSilta Ltd (Biosilta) is a biotechnology company that develops and markets reagent based microbial growth systems and accessories. The company offers products, which include enpresso growth systems, flasks, plates and seals. Its enpresso growth systems are used in the production of recombinant proteins. Biosilta’s enbase is a technology platform that controls the feeding and growth rate of microbial cultures and used to develop reagent-based enpresso growth systems. The company produces recombinant proteins for research purposes. It conducts research and development to develop new drugs. The company serves the needs of life science research companies. It markets its products through a network of distributors in Finland, the US, Japan, the UK, Canada, Australia, New Zealand, and others. Biosilta is headquartered in St. Ives, the UK.

BioSilta Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioSilta Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioSilta Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioSilta Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioSilta Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
BioSilta Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
Biosilta Raises USD3.4 Million in Venture Financing 9
Partnerships 10
BioSilta Enters into Co-Marketing Agreement with Sigma-Aldrich 10
Licensing Agreements 11
BioSilta Enters into Licensing Agreement with University of Oulu 11
BioSilta Ltd – Key Competitors 12
BioSilta Ltd – Key Employees 13
BioSilta Ltd – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
BioSilta Ltd, Pharmaceuticals & Healthcare, Key Facts 2
BioSilta Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
BioSilta Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioSilta Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioSilta Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioSilta Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Biosilta Raises USD3.4 Million in Venture Financing 9
BioSilta Enters into Co-Marketing Agreement with Sigma-Aldrich 10
BioSilta Enters into Licensing Agreement with University of Oulu 11
BioSilta Ltd, Key Competitors 12
BioSilta Ltd, Key Employees 13

★海外企業調査レポート[BioSilta Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kohlberg Kravis Roberts & Co LP:企業のM&A・事業提携・投資動向
    Kohlberg Kravis Roberts & Co LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kohlberg Kravis Roberts & Co LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • New Zealand Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary New Zealand Pharmaceuticals Ltd (NZP) a subsidiary of Archer Capital, manufactures and supplies pharmaceutical intermediates and diagnostic products for pharmaceutical and microbiological media companies. It also offers biochemicals and natural extracts for health, cosmetic, biotechnology, f …
  • Esab Holdings Ltd:企業の戦略・SWOT・財務分析
    Esab Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Esab Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Aquila Resources Ltd:企業の戦略・SWOT・財務分析
    Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hanmi Pharmaceuticals Co Ltd (128940)-医療機器分野:企業M&A・提携分析
    Summary Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company’s prescription drugs include osteoporosis, antibiotics, antidiarrheal, liver supplements and antiemetics. It provides over the counte …
  • Weizmann Institute of Science:製薬・医療:M&Aディール及び事業提携情報
    Summary Weizmann Institute of Science (WIS) is a research institute that offers research activities in the field of natural and exact sciences. The institute provides programs that include graduate programs, post graduate programs, scientific research, academic affairs, science education, research a …
  • Cosan Ltd:企業の戦略・SWOT・財務情報
    Cosan Ltd - Strategy, SWOT and Corporate Finance Report Summary Cosan Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • George Weston Ltd (WN):企業の財務・戦略的SWOT分析
    George Weston Ltd (WN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Mapfre Middlesea p.l.c.:企業の戦略・SWOT・財務分析
    Mapfre Middlesea p.l.c. - Strategy, SWOT and Corporate Finance Report Summary Mapfre Middlesea p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Advantage Oil & Gas Ltd. (AAV)-石油・ガス分野:企業M&A・提携分析
    Summary Advantage Oil & Gas Ltd. (Advantage Oil) is an upstream company that exploits, develops, acquires, and produces natural gas and liquids in Alberta. Its exploitation and development program is focused at Glacier. The company’s acreage is spread throughout the Western Canadian Sedimentary Basi …
  • Symbiotec Pharmalab Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Symbiotec Pharmalab Ltd (Symbiotec) is a medical laboratory that manufactures active pharmaceutical ingredients. The laboratory develops, produces and markets research-based cortico steroids and steroid-hormone APIs. Its cortico-steroids APIs include clobetasol propionate, betamethasone dipr …
  • SunPower Corporation:企業の戦略・SWOT・財務情報
    SunPower Corporation - Strategy, SWOT and Corporate Finance Report Summary SunPower Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Impax Laboratories Inc (IPXL)-製薬・医療分野:企業M&A・提携分析
    Summary Impax Laboratories Inc (Impax) develops, manufactures and markets generic and branded pharmaceuticals. It offers solid dose and alternative dosage form generic drugs in a broad range of therapeutic areas; and proprietary branded pharmaceutical products for the treatment of central nervous sy …
  • Isofol Medical AB (ISOFOL):製薬・医療:M&Aディール及び事業提携情報
    Summary Isofol Medical AB (Isofol) is a clinical stage pharmaceutical company that develops folate-based therapies for the treatment of cancer patients. The company offers clinical lead candidate Modufolin, a novel folate-based therapy, which is developed to increase the efficacy and reduce the side …
  • MAMEE-Double Decker (M) Sdn Bhd:企業の戦略的SWOT分析
    MAMEE-Double Decker (M) Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Navigant Consulting Inc (NCI):企業の財務・戦略的SWOT分析
    Summary Navigant Consulting Inc (Navigant Consulting) is a consultancy service provider that provides integrated solutions to assist companies and legal counsel in improving stakeholder value and operations. The company offers growth strategy, operations and transaction advisory services such as str …
  • Swelect Energy Systems Ltd (SWELECTES):企業の財務・戦略的SWOT分析
    Summary Swelect Energy Systems Ltd(SESL), is an energy company that manufactures and markets renewable energy products and iron and steel products. The company’s renewable energy products include solar pv modules, solar inverter, solar water pump and energy efficient lighting. SESL offers iron and s …
  • Capture Vascular Inc-医療機器分野:企業M&A・提携分析
    Summary Capture Vascular Inc (Capture Vascular) is a medical device development company that offers mechanical thrombectomy systems. The company offers MegaVac, a mechanical thrombectomy system that removes clots in arteries and provides vessel occlusion, embolic prevention and anchoring capabilitie …
  • Shinsegae Inc (004170):企業の財務・戦略的SWOT分析
    Shinsegae Inc (004170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Fidia farmaceutici SpA-製薬・医療分野:企業M&A・提携分析
    Summary Fidia farmaceutici SpA (Fidia), a subsidiary of P&R S.p.A., is a healthcare products provider that specializes in research, development and manufacturing of hyaluronic acid-based products. The company develops and commercializes products for specific therapeutic areas which includes joint he …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆